About liquidia corp - LQDA
Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.
LQDA At a Glance
Liquidia Corp.
419 Davis Drive
Morrisville, North Carolina 27560
| Phone | 1-919-328-4400 | Revenue | 158.32M | |
| Industry | Pharmaceuticals: Major | Net Income | -68,924,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 1,031.18% | |
| Fiscal Year-end | 12 / 2026 | Employees | 216 | |
| View SEC Filings |
LQDA Valuation
| P/E Current | 50.326 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 18.748 |
| Price to Book Ratio | 67.214 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -59.69 |
| Enterprise Value to Sales | 18.794 |
| Total Debt to Enterprise Value | 0.067 |
LQDA Efficiency
| Revenue/Employee | 732,962.963 |
| Income Per Employee | -319,092.593 |
| Receivables Turnover | 2.927 |
| Total Asset Turnover | 0.561 |
LQDA Liquidity
| Current Ratio | 2.014 |
| Quick Ratio | 1.838 |
| Cash Ratio | 1.404 |
LQDA Profitability
| Gross Margin | 91.113 |
| Operating Margin | -32.451 |
| Pretax Margin | -43.535 |
| Net Margin | -43.535 |
| Return on Assets | -24.409 |
| Return on Equity | -112.969 |
| Return on Total Capital | -28.402 |
| Return on Invested Capital | -37.765 |
LQDA Capital Structure
| Total Debt to Total Equity | 442.315 |
| Total Debt to Total Capital | 81.561 |
| Total Debt to Total Assets | 59.694 |
| Long-Term Debt to Equity | 310.704 |
| Long-Term Debt to Total Capital | 57.292 |